David D. Helsel

David D. Helsel

SVP, Global Operations and R&DatAngiodynamics· In proxies 2021–2023

Pay in FY2023-23% from the year before · Angiodynamics stock -51.8% the same year

David D. Helsel was paid $785.6K in FY2023 (May), down 23%. Angiodynamics stock fell 51.8% that year.

Pay$100 in the stock at the end of FY20 → $93
Pay is from the Summary Compensation Table of each Angiodynamics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AngiodynamicsPublic company · 5 yr
    • SVP, Global Operations and R&D2021 – Present · 5 yrStock in role +8%

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?